Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Viatris Stock: Analyst Estimates & Ratings

Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, operates as a healthcare company. With a market cap of $10.3 billion, the company produces medicines for patients across a broad range of major therapeutic areas spanning both noncommunicable and infectious diseases. 

Shares of this global healthcare giant have considerably underperformed the broader market over the past year. VTRS has declined 24.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 18.4%. In 2025, VTRS stock is down 28.2%, compared to the SPX’s 7.6% rise on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.